These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17080408)

  • 1. Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants.
    Peek LJ; Martin TT; Elk Nation C; Pegram SA; Middaugh CR
    J Pharm Sci; 2007 Mar; 96(3):547-57. PubMed ID: 17080408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
    Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens.
    Jones LS; Peek LJ; Power J; Markham A; Yazzie B; Middaugh CR
    J Biol Chem; 2005 Apr; 280(14):13406-14. PubMed ID: 15684430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting alum-protein interactions.
    Huang M; Wang W
    Int J Pharm; 2014 May; 466(1-2):139-46. PubMed ID: 24607202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuvanted vaccines.
    Ausar SF; Chan J; Hoque W; James O; Jayasundara K; Harper K
    J Pharm Sci; 2011 Feb; 100(2):431-40. PubMed ID: 20740682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.
    Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J
    PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to Prepare Aluminum Salt-Adjuvanted Vaccines.
    Thakkar SG; Cui Z
    Methods Mol Biol; 2017; 1494():181-199. PubMed ID: 27718194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution.
    Vessely C; Estey T; Randolph TW; Henderson I; Cooper J; Nayar R; Braun LJ; Carpenter JF
    J Pharm Sci; 2009 Sep; 98(9):2970-93. PubMed ID: 18680175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
    Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
    Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
    DePaz RA; Henderson I; Advant SJ
    Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine.
    Peek LJ; Brey RN; Middaugh CR
    J Pharm Sci; 2007 Jan; 96(1):44-60. PubMed ID: 16998874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants.
    Vessely C; Estey T; Randolph TW; Henderson I; Nayar R; Carpenter JF
    J Pharm Sci; 2007 Sep; 96(9):2375-89. PubMed ID: 17518359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear effects on aluminum phosphate adjuvant particle properties in vaccine drug products.
    Kolade OO; Jin W; Tengroth C; Green KD; Bracewell DG
    J Pharm Sci; 2015 Feb; 104(2):378-87. PubMed ID: 25175154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
    Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
    Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced immune responses by co-adsorption of liposomal adjuvant formulations to the aluminum-antigen complex.
    Park K
    J Control Release; 2018 Apr; 275():269. PubMed ID: 29599029
    [No Abstract]   [Full Text] [Related]  

  • 16. Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: effect of charge, fluidity and antigen-to-lipid ratio.
    Hamborg M; Rose F; Jorgensen L; Bjorklund K; Pedersen HB; Christensen D; Foged C
    Biochim Biophys Acta; 2014 Aug; 1838(8):2001-10. PubMed ID: 24769435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
    Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
    Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants.
    Ljutic B; Ochs M; Messham B; Ming M; Dookie A; Harper K; Ausar SF
    Vaccine; 2012 Apr; 30(19):2981-8. PubMed ID: 22381074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines.
    Shi Y; HogenEsch H; Hem SL
    Vaccine; 2001 Oct; 20(1-2):80-5. PubMed ID: 11567749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminum adjuvant dose guidelines in vaccine formulation for preclinical evaluations.
    Vecchi S; Bufali S; Skibinski DA; O'Hagan DT; Singh M
    J Pharm Sci; 2012 Jan; 101(1):17-20. PubMed ID: 21918987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.